Jump to content

Thai FDA urges Mie Sedaap distributor to order sales suspension of all flavours available


snoop1130

Recommended Posts

241670508_869347067037686_2174542204425790625_n-664x420.jpeg

PHOTO: Mi Sedaap TH - หมี่ซีดาพ

 

The Thai Food and Drug Administration (FDA) on Friday, October 21st, ordered a selling suspension of all Mie Sedaap instant noodles from Indonesia, after they detected ethylene oxide, a substance commonly found in pesticides, in Mie Sedaap flavours sold in Thailand.

 

The FDA conducted the test after the Singapore Food Agency reported the presence of ethylene oxide in Mie Sedaap Korean Spicy Soup instant noodles and Korean Spicy Chicken instant noodles on October 6th. Later, the Thai FDA initially stated that the exact flavours were not imported to Thai market.

 

However, the flavours sold in Thailand were initially taken for a test. Two lots of Mie Sedaap Korean Spicy Chicken, one dated 25 Nov 21 and expired 25 Nov 22 and another one dated 07 Dec 21 and expired 07 Dec 22, found the presence of the dangerous substance.

 

Full Story: https://thepattayanews.com/2022/10/21/thai-fda-urges-mie-sedaap-distributor-to-order-sales-suspension-of-all-flavours-available-in-thailand-after-pesticide-ethylene-oxide-allegedly-found-in-initial-lab-test/

 

PattayaNews.jpg
-- © Copyright The Pattaya News 2022-10-21
 

- Cigna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here.

 

Monthly car subscription with first-class insurance, 24x7 assistance and more in one price - click here to find out more!

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.










×
×
  • Create New...